Publications by authors named "Izabela Obarska"
Ann Rheum Dis
September 2023
Article Synopsis
- Access to biologic drugs for rheumatic musculoskeletal diseases remains unequal, but the introduction of biosimilars holds promise for better affordability and access.
- A budget impact analysis of TNFi treatment showed significant cost savings, estimating over €243 million in savings for public payers over eight years, with €166 million specifically from reduced treatment costs.
- The study highlights the potential to treat nearly 45,000 additional patients if savings are reinvested, calling for clear guidelines on how to utilize these financial benefits effectively.
